CSIMarket Company Name, Ticker, Competitors, else..


Bristol myers Squibb Company  (NYSE: BMY)
Other Ticker:  
 

Bristol myers Squibb Company

BMY's Fundamental analysis



Looking into Bristol Myers Squibb growth rates, revenue grew by 7.54 % in IV. Quarter 2024 from the same quarter a year ago. Ranking at No. 331

Major Pharmaceutical Preparations industry recorded growth of revenues by 11.85 %

Bristol Myers Squibb's net profit decreased by -95.69 % in IV. Quarter 2024 year on year, to $76 millions.

• More on BMY's Growth


Bristol Myers Squibb
realized a net loss in trailing twelve months.

Bristol Myers Squibb realized cash reduction of $ -0.58 per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 2.07.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.1.


• More on BMY's Valuation
 
 Total Debt (Millions $) 49,649
 Dividend TTM ($) 2.4 $
 Dividend Yield TTM (%) 4.88 %
 Revenue/Employee (TTM) $ 1,416,422
 Net Income/Employee (TTM) $ -261,965
 Receivable Turnover (TTM) 4.43
 Tangible Book Value (Per Share $) -14.11

Bristol Myers Squibb
realized net loss in trailing twelve months.

Bristol Myers Squibb realized cash outflow of $ -0.58per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 2.07.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.1.

Bristol Myers Squibb Price to Book Ratio is at 6.1 lower than Industry Avg. of 77.28. and higher than S&P 500 Avg. of 0.01

• More on BMY's Valuation

•  Market Capitalization (Millions $) 99,889
•  Shares Outstanding (Millions) 2,029
•  Employees 34,100
•  Revenues (TTM) (Millions $) 48,300
•  Net Income (TTM) (Millions $) -8,933
•  Cash Flow (TTM) (Millions $) -1,172
•  Capital Exp. (TTM) (Millions $) -1,248
•  Total Debt (Millions $) 49,649
•  Dividend TTM ($) 2.4 $
•  Dividend Yield TTM (%) 4.88 %
•  Revenue/Employee (TTM) $ 1,416,422
•  Net Income/Employee(TTM) $ -261,965
•  Receivable Turnover Ratio (TTM) 4.43
•  Tangible Book Value (Per Share $) -14.11

•  Market Capitalization (Millions $) 99,889
•  Shares Outstanding (Millions) 2,029
•  Employees 34,100
•  Revenues (TTM) (Millions $) 48,300
•  Net Income (TTM) (Millions $) -8,933
•  Cash Flow (TTM) (Millions $) -1,172
•  Capital Exp. (TTM) (Millions $) -1,248


    BMY's Profitability Comparisons
Bristol Myers Squibb faced margin deterioration, primarily through cost pressure. Operating Margin fell in IV. Quarter 2024 to 3.89 % from 16.06 % in III. Quarter.

Bristol Myers Squibb net profit margin of 0.62 % is currently ranking no. 66 in Major Pharmaceutical Preparations industry, ranking no. 197 in Healthcare sector and number 2279 in S&P 500.


Profitability by Segment
Total 10.22 %



  Ratio
•   Capital Ratio (MRQ) 1.25
•  Total Debt to Equity (MRQ) 3.03
•  Tangible Leverage Ratio (MRQ) -
•  Asset Turnover Ratio (TTM) 0.53
•  Inventory Turnover Ratio (TTM) 4.68



Bristol Myers Squibb faced margin deterioration, primarily through cost pressure. Operating Margin fell in IV. Quarter 2024 to 3.89 % from 16.06 % in III. Quarter.

Bristol Myers Squibb net profit margin of 0.62 % is currently ranking no. 66 in Major Pharmaceutical Preparations industry, ranking no. 197 in Healthcare sector and number 2279 in S&P 500.

• More on BMY's Key Ratios





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com